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1. Introduction 
Protein mimicry of DNA is a recently discovered direct mechanism of regulation of DNA-
dependent enzyme activity by means of proteins that mimic DNA structure and interact 
with a target enzyme and completely inhibit (or modulate) its activity. DNA-mimicking 
inhibitor proteins bind directly to the enzyme and thus blocks or alters the activity of the 
latter. Protein mimicry of DNA was first described in Ugi derived from PBS2 bacteriophage 
of Bacillus subtilis (Mol et al, 1995). This protein of 84 amino acid residues with a total charge 
of (–12) inhibits uracil-DNA glycosylase (UDG), an enzyme involved in DNA repair (Mol et 
al, 1995; Putnam & Tainer, 2005). Subsequently, this type of protein mimicry was found in 
the ribosomal elongation factor EF-G (tRNA-like motif), and in the dTAFII 230 component 
of eukaryotic transcription factor TFIID (DNA-like domain) (Liu et al., 1998). The family of 
DNA mimetics further includes DinI, a negative SOS response regulator in E. coli (Ramirez 
et al., 2000), and a nucleosome forming protein HI1450 of Haemophilus influenzae (Parsons et 
al., 2004). However, in most of these cases, only a part of the protein molecule is DNA-like, 
in contrast to antirestriction and pentapeptide repeat (PPR) proteins, whose entire structure 
mimics the B-form of DNA. For instance, the X-ray structure of Ugi reveals a domain similar 
to the B-form of DNA, but the molecule as a whole is globular. Note that, in Ugi, the crucial 
negative charges are those of E20, E28, and E31 in the N domain (Mol et al.,1995). 
Horizontal gene transfer is a fundamental mechanism for driving diversity and evolution. 
Transmission of DNA to bacterial cells that are not direct descendants of the donor is often 
achieved via mobile genetic elements such as plasmids, conjugative transposons and 
bacteriophages. Mobilization of these elements can lead in the spread of antimicrobial 
resistance in clinical environments and in the wider community. 
Over 50% of eubacteria and archaea contain the genes for one or more of the four classes of 
known DNA restriction and restriction-modification (RM) systems (Roberts et al., 2005). RM 
systems work by recognizing specific DNA sequences and triggering an endonuclease 
activity which rapidly cleaves the foreign DNA allowing facile destruction by exonucleases 
(Bickle & Kruger,1993; Murray, 2000; Loenen, 2003). 
Mobile genetic elements such as plasmids, transposons and bacteriophage contain the 
specific genes encoding anti-RM systems. Activation of anti-RM system weakens or negates 
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the RM defence system allowing further horizontal gene transfer (Wilkins, 1995; 
Zavilgelsky, 2000; Murray, 2002; Tock & Dryden, 2005). 
The genes encoding antirestriction proteins are situated on conjugational plasmids (ardA gene) 
and some bacteriophages (ocr and darA genes). Antirestriction proteins inhibit the type I 
restriction-modification enzymes and thus protect unmodified DNA of plasmids and 
bacteriophages from degradation. Genes ard (alleviation of restriction of DNA) facilitate the 
natural DNA transfer between various types of bacteria ensuring overcoming intercellular 
restriction barriers (horizontal genes transfer). Genes ocr (bacteriophage T7) and darA 
(bacteriophage P1) significantly increase the infection efficiency by phages of the bacterial cells. 
Antirestriction proteins ArdA and Ocr belong to the group of very acidic proteins and contain 
a characteristic sequence of negative charges (Asp and Glu). X-ray diffraction study of 
proteins ArdA and Ocr carried out demonstrated that these proteins were like the B-form of 
DNA (Walkinshaw et al., 2002; McMahon et al., 2009). Therefore the antirestriction proteins 
operate on the principle of concurrent inhibition replacing DNA in the complex with the 
enzyme (DNA mimicry). 
DNA-mimetic antirestriction proteins ArdA and Ocr can be electroporated into cells along 
with transforming DNA and protect unmodified DNA from degradation. As a result the 
antirestriction proteins improve transformation efficiency. The highly charged, very acidic 
proteins Ocr and ArdA can be used as a purification handle similar to other fusion tags. A 
monomeric mutant of the Ocr protein was used as a novel fusion tag which displayed 
solubilizing activity with a variety of different passenger proteins (DelProposto et al., 2009).  
The pentapeptide repeat is a recently discovered protein fold. MfpA and Qnr (A,B,C,D,S) 
are two newly characterized pentapeptide repeat proteins (PPRs) that interact with type II 
topoisomerase (DNA gyrase) and confer bacterial resistance to the drugs quinolone and 
fluoroquinolone [Hegde et al., 2005; Hedge et al., 2011). The mfpA gene is chromosome 
borne in Mycobacterium tuberculosis (Hegde et al., 2005; Montero et al., 2001), while qnr genes 
are plasmid borne in Gram-negative enterobacteria (Martinez-Martinez, L. et al.,1998; Tran 
et al., 2005; Cattoin & Nordmann, 2009; Rodriguez-Martinez et al. 2011). The size, shape, and 
surface potential of MfpA and Qnr proteins mimics duplex DNA (Hegde et al., 2005; Vetting 
et al., 2009; Hegde et al., 2011). 
2. Type I restriction-modification systems 
Restriction–modification (RM) systems form a barrier protecting a cell from the penetration 
by foreign DNA (Murray, 2000; Loenen, 2003). In the modern understanding, RM enzymes 
are a part of the “immigration control system”, which discriminates between its own and 
foreign DNA entering the cell (Murray, 2002). The system is based on two conjugated 
enzymatic activities: those of restriction endonucleases and DNA methyltransferases. RM 
enzymes recognize a specific nucleotide sequence in the DNA, and the restriction 
endonuclease cleaves the double strand of unmodified DNA. The host DNA is protected 
from enzymatic cleavage by specific methylation of the recognition sites produced by DNA 
methyltransferases. RM enzymes are classified in four types. We shall now discuss the 
features of type I RM systems, since it is these systems that are efficiently inhibited by 
antirestriction proteins. Figure 1 schematically represents the activity of a type I enzyme, 
e.g., EcoKI. EcoKI comprises five subunits (R2M2S): two R subunits are restriction 
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endonucleases that cleave the double helix of unmodified DNA, two M subunits are 
methyltransferases that methylate adenine residues at the recognition site, and an S subunit 
recognizes a specific DNA site (sK) and forms a stable complex with it. 
 
Fig. 1. Activity of a type I restriction–modification enzyme. 1, Both DNA strands at the sK 
site are methylated. The enzyme–DNA complex dissociates. 2, One of DNA strands at the 
sK site is methylated. The methylase (M) methylates the adenyl residue of the other strand, 
and the complex dissociates.  3, Both DNA strands at the sK site are unmethylated. The 
enzyme initiates DNA translocation through the R subunits accompanied by the formation 
of a supercoiled loop and subsequent double-stranded DNA break. 
The sK site is “hyphenated”, i.e., only seven outmost nucleotides of the 13 bp long recognition 
sequence are conserved (e.g. EcoKI recognizes 5’-AACNNNNNNGTGC-3’). According to the 
footprinting data, EcoKI covers 66 bp of the DNA sequence. Further events depend on the sK 
status. If both DNA strands at the site are methylated, the complex dissociates.  
If only one strand is methylated, the methylase M methylates the respective adenyl residue, 
and the complex dissociates. If both DNA strands are unmethylated, the DNA helix is 
translocated through the R subunits, while the S subunit remains bound to the sK site. The 
endonuclease R randomly cleaves the DNA strands at a considerable  distance from the sK 
site. This is the principal difference between the type I RM enzymes and type II restriction 
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endonucleases, which introduce a double-strand DNA break directly at the recognition site or 
at a specific distance from it. The translocation process itself is associated with considerable 
energy expenditure in  the form of ATP. As a result, type I RM enzymes are ATP-dependent, 
whereas type II enzymes are not. Another characterizing feature of the EcoKI–sK complex is 
that the S subunit binds only to the outmost conserved nucleotides of the site. As a result, the 
double stranded DNA undergoes significant deformation, acquiring a kink of approximately 
34°, which sets additional energy demands. Nucleotide sequences of the recognition sites vary 
and are specific for each type I enzyme (EcoK, EcoB, EcoA, EcoD, Eco124, StyLT, StySP, CfrAI, 
and many others). Based on their homology and the possibility of subunit exchange, type I RM 
systems are classified into four families: IA, IB, IC, ID. Restriction is efficient against foreign 
DNA irrespective of the way it is introduced into the cell: by injection from a phage, 
transformation, or conjugative transmission. Thus, type I RM systems constitute a socalled 
restriction barrier that prevents interspecies horizontal gene transfer. 
3. Conjugative plasmids and transposons, bacteriophages, and 
antirestriction 
Natural horizontal gene transfer between bacteria is mediated primarily by transmissible 
plasmids, conjugative transposones, and bacteriophages (Wilkins, 1995). Evolution of all 
transmissible plasmids, conjugative transposones and some bacteriophages gave rise to 
systems enabling them to overcome restriction barriers. This phenomenon has been termed 
antirestriction (Zavilgelsky, 2000; Tock & Dryden, 2005). An investigation of antirestriction 
mechanisms employed by transmissible plasmids showed that the process involves a 
specialized antirestriction protein encoded by the ardA gene (alleviation of restriction of 
DNA). ardA genes were first discovered in plasmids of the incompatibility group N in 1984–
1985 (Belogurov et al.,1985), and later in other types of plasmids (Kotova et al., 1988; Delver 
et al., 1991). In 1991–1995, ardA genes were sequenced and the primary structure of ArdA 
proteins was determined (Delver et al., 1991; Chilley & Wilkins, 1995). Genes ardA are 
located in the leader region of the plasmid sequence, which lies next to oriT and is the first to 
enter the host cell in the course of conjugative transfer. The oriT site, the origin of plasmid 
conjugative replication, is located at the boundary of the tra operon with the rest of plasmid. 
The conjugative transposon Tn916 of the bacterial pathogen Enterococcus faecalis contains orf18 
gene, which is located within position region and encodes an ArdA antirestriction protein 
(Serfiotis-Mitsa et al., 2008). Genes of the ardA family encode small, very acidic proteins 
comprised of 160–170 amino acid residues and bearing a characteristic total negative charge of 
(–20 to –30) which act as specific highly efficient inhibitors of cellular type I RM enzymes. 
ArdA proteins inhibit restriction endonucleases of different families (IA, IB, IC, and ID) and 
with different recognition site sequences with nearly the same efficiency. Thanks to this 
property of ArdA, transmissible plasmids can overcome the restriction barriers through 
horizontal transmission from the donor cell into bacteria of various species and genera. 
Some bacteriophages also possess genes encoding antirestriction proteins, such as 0.3(ocr ) 
(phage T7) and darA (phage P1) (Dunn et al., 1981; Kruger et al., 1983; Iida et al., 1988). 
These genes increase the efficiency of phage infection. 
Antirestriction proteins, both of plasmid (ArdA) and phage origin (Ocr), inhibit only type I 
RM enzymes, whose genes (hsdRMS) are usually located on the bacterial chromosome, but 
not type II restriction endonucleases, the genesof which are normally located on plasmids. 
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4. DNA mimicry by antirestriction proteins 
It has been supposed that antirestriction proteins of the ArdA family, as well as Ocr are 
modulator proteins with a structure similar to that of the B-form DNA, and the characteristic 
surface distribution of negatively charged D and E residues (aspartic and glutamic acids) 
imitates the distribution of negatively charged phosphate groups along the DNA double helix 
(Zavilgelsky, 2000). That is, antirestriction proteins imitate the DNA structure, which is 
currently termed “protein mimicry of DNA”. The spatial structure of the smallest 
antirestriction protein, Ocr of phage T7 (116 amino acids), was published in 2002 (Walkinshaw 
et al., 2002). As shown by X-ray crystallography, the spatial structure of Ocr was similar to the 
B-form of DNA (Fig. 2). The major stem of the Ocr monomer is constituted by three ǂ-helices: 
A (residues 7–24), B (residues 34– 44), and a long, somewhat bent one, D (residues 73–106); the 
helices form a tightly packed bunch with strictly regularly positioned negatively charged D 
and E carboxyls along the stem axis, nearly reproducing the distribution of negatively charged 
phosphate groups along DNA double helix. The short ǂ-helix C (residues 49–57) is a part of 
the interface determining the contact of monomers and stable dimer formation. 
The structure of the Ocr dimer, both in solution and in crystal form, is similar in length and 
charge distribution to 24 bp of DNA double helix. The contact of monomers is established 
by a Van der Waals interaction between hydrophobic clusters within the C ǂ-helices in the 
middle of the polypeptide: A50, F53, S54, M56, A57, and V77.  
 
Fig. 2. Spatial structure of the (Ocr)2 protein dimer. Shown is the positioning of   ǂ-helices A, 
B, C, D, and amino acid residues 53F and 57A in the hydrophobic cluster 52IFSVMAS, 
which determines the Van der Waals attraction of the monomers. 
The spatial structure of the ArdA protein from the conjugative transposon Tn916 (166 amino 
acids), was published in 2009 (McMahon et al., 2009). As was shown by X-ray 
crystallography, ArdA protein has a extremely elongated curved cylindrical structure witn 
defined helical groowes. The high density of Asp and Glu residues on the surface follow a 
helical pattern and the whole protein mimics a 42-base pair stretch of B-form DNA making 
ArdA dimer by far the largest DNA mimic known (Fig. 3). Each monomer of this dimeric 
structure can be decomposed into three domains: the N-terminal domain 1 (residues 3-61), 
the central domain 2 (residues 62-103) and the C-terminal domain 3 (residues 104-165). The 
N-terminal domain 1 consists of a three-stranded anti-parallel ǃ-sheet and one short ǂ -helix 
interspersed with three large loops of 10 or more residues. The central domain 2 of ArdA is 
a four ǂ–helix bundle. The C-terminal domain 3 has a three-stranded ǃ -sheet and three ǂ-
helices packed together in a manner that creates a groove in the structure 11 angstrem wide. 
Analysis of the electrostatic surface of ArdA shows that 2 and 3 domains have a profoundly 
negative potential (the pI of ArdA is 4). The ArdA dimer, like the monomer, is highly 
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elongated and curved (Fig. 3). The chord that connects the extreme ends has the length of 
140 angstrem. The pattern of negative charge even extends across the dimer interface 
through the conserved residues D109, D111, D112, D115, E122, E123 and E129.  
This distribution and conservation of charged residues is evidence for the necessity of dimer 
formation for protein function and suggests that ArdA across all species will have similar 
structural requirements. The dimer interface contains the anti-restriction motif (amino acids 
126-140 in the Tn916 ArdA protein) identified previously (Belogurov & Delver, 1995) 
conserved as well. 
 
Fig. 3. Spatial structure of the (ArdA)2 protein dimer. 
The ArdA dimer appears to mimic about 42 bp of bent B-form DNA. This is comparable in 
length to the footprint of the EcoKI Type IA RM enzyme, without its cofactors, on DNA. In 
comparison, the Ocr dimer from phage T7 mimics only about 24 bp., similar in length to the 30 
bp footprint of the Type I RM enzyme in the presence of its cofactors and to the footprint of the 
MTase core, M.EcoKI, of the Type I RM enzyme. The typical DNA target for a Type I RM 
enzyme is 14 bp long and bipartite, e.g. EcoKI recognizes 5’-AACNNNNNNGTGC-3’, and lies 
centrally in the experimental DNA footprint. It was built the M.EcoKI-ArdA model: domain 3 
overlaps the EcoKI target sequence, domain 2 contacts the extremites of the DNA-binding 
groove in M.EcoKI and domain 3 projects beyond the M.EcoKI structure. Domain 1 is not 
essential for antirestriction as it can be deleted (Delver et al., 1991) indicating that the key 
aspect of antirestriction by ArdA is the binding to the MTase core using domains 2 and 3. 
The mimicry of DNA enables antirestriction proteins to compete with DNA for binding with 
the RM enzyme and thus to inhibit DNA degradation (restriction) and methylation 
(modification). From the point of view of classical enzymatic catalysis, antirestriction is a 
case of competitive inhibition based on structural similarity between the enzyme substrate 
and the inhibitor molecule. The relative positioning of monomers in the (Ocr)2 dimer is 
typical: the angle between their longitudinal axes is approximately 34° (Fig. 2). This dimer 
structure is nearly equivalent to the kinked DNA double helix structure that is formed at the 
recognition site of the type I RM enzyme–DNA complex (Murray, 2000). Consequently, Ocr 
does not require additional energy to bind to EcoKI, and efficiently displaces double-
stranded DNA from the complex (the complex formation constant for Ocr–EcoKI is 
approximately 100 times higher than for DNA–EcoKI) (Atanasiu et al., 2002).  
5. Antirestriction and antimodification activities of ArdA and Ocr proteins 
Both ArdA and Ocr inhibit ATP-dependent type I RM enzymes. However, the great difference 
between the life cycles of transmissible plasmids (symbiosis with a bacterial cell) and 
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bacteriophages (infection and lysis of bacteria) makes it interesting to compare the inhibition 
efficiencies of these proteins. For this purpose, we cloned ardA and ocr under a strictly 
regulated promoter. To quantify the intracellular concentration of the antirestriction proteins, 
we developed a bioluminescence method that utilizes the Photorhabdus luminescens luxCDABE 
genes as reporters. The luxCDABE genes were cloned in the pZE21 and pZS33 vectors under 
the control of the PltetO_1 promoter. The hybrid plasmids were introduced in MG1655Z1 cells. 
Expression of the lux genes was induced by adding anhydrotetracycline in the medium, and 
the bioluminescence intensity was measured. Since the bioluminescence intensity is directly 
proportional to the luciferase concentration and the sensitivity of the bioluminescence method 
is high, it is possible to estimate the enzyme concentration in the cell within a broad range, 
starting with extremely low concentrations. A calibration plot was constructed to characterize 
the intracellular content of the enzyme (in relative units (RU)) as a function of the inductor 
(anhydrotetracycline) concentration (Fig. 4). The luciferase content in MG1655Z1 cells varied 
from 1 (in the absence of anhydrotetracycline) to 5000 (20 ng/ml anhydrotetracycline or more) 
RU. It is natural to assume that the relative contents of the proteins synthesized from the ardA 
and 0.3(ocr) genes cloned in the pZE21 and pZS33 vectors vary within the same range as the 
luciferase content under the same expression conditions. 
To measure the antirestriction activities of the ArdA and Ocr proteins, titration with phage λ.0 
was performed for MG1655Z1 cells carrying a hybrid plasmid with the ardA or 0.3(ocr) gene; 
cells without the hybrid plasmid were used as a control. Since the genome of strain 
MG1655Z1 contains the hsdRMS genes, which code for the EcoKI restriction–modification 
enzyme, the phage λ.0 seeding efficiency was approximately four orders of magnitude 
lower than in the case of control strain TG_1. However, when MG1655Z1 cells contained a 
plasmid with the cloned ardA or 0.3(ocr) gene, the phage seeding efficiency changed 
depending on the production of the antirestriction protein. As the protein production 
increased, the phage seeding efficiency grew from 10–4 (no inhibition) to 1 (complete 
inhibition of restriction–modification enzymes). 
 
Fig. 4. Luciferase content (relative units, RU) in E. coli MG1655Z1 cells containing the 
pZS33_lux or pZE21_lux plasmid as a function of anhydrotetracycline content. The P. 
luminescens luxCDABE genes were cloned in the pZS33 and pZE21 vectors under the control 
of the P1tetO_1 promoter. The luciferase content in the presence of the pZS33_lux plasmid 
and the absence of the inductor anhydrotetracycline was taken as unity. 
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ArdA ColIb-P9, Ocr T7 antirestriction and antimodification activities were avaluated as a 
function of the inhibitor concentration, that enabled us to estimate the relative difference in 
dissociation constants ( K d ) that describe the interaction efficiency for ArdA or Ocr and 
EcoKI (Fig. 5) (Zavilgelsky et al., 2008).  
 
Fig. 5. Antirestriction activity of ArdA ColIb-P9, Ocr T7, and Ocr mutant F53D A57E as a 
function of their intracellular levels. X-axis: intracellular antirestriction protein concentration 
(relative units). Y-axis: Antirestriction activity (unmodified λ DNA was used as an EcoKI 
target). Dotted lines indicate the Kd points. Circles, native Ocr; squares, Ocr F53D A57E; 
triangles, ArdA. 
The antimodification activity of the ArdA and Ocr proteins was inferred from the seeding 
efficiency of phage λMG1655Z1 (phage λ.0 propagated for one cycle in MG1655Z1 cells carrying a 
plasmid with the ardA or 0.3(ocr) gene) on strains AB1167 r+m+ and TG1 r–m–. The ratio 
between the phage titers on these strains reflected the extent of phage DNA modification 
(methylation). The ardA and 0.3(ocr) genes were cloned in the pZE21 and pZS33 vectors with 
the strongly regulated PltetO-1 promoter; the results are summarized in Tables 1 and 2. The 
intracellular concentrations of the ArdA and Ocr proteins were estimated from the calibration 
plot constructed by the bioluminescence method (Fig. 1). The ArdA and Ocr proteins 
substantially differed in the capability of inhibiting the EcoKI enzyme. The Ocr protein almost 
completely inhibited the EcoKI restriction–modification system, affecting both restriction and 
modification activities of the enzyme in a broad Ocr concentration range. The effect was 
already detectable when Ocr was present at several tens of molecules per cell (1 RU 
corresponds approximately to ten molecules of the inhibitor protein per cell) (Table 1). 
In the case of the ColIb_P9 ArdA protein, the efficiency of inhibition of the restriction 
activity of the EcoKI enzymes started to decrease when the protein concentration was 
approximately half its threshold value (which corresponded to complete inhibition of EcoKI 
activity), that is, when ArdA occurred at 10000– 15000 molecules per cell. Inhibition of 
modification activity of the EcoKI enzyme started at higher intracellular ArdA 
concentrations, at approximately 45000–50000 ArdA molecules per cell (Table 2). 
The antirestriction and antimodification activities of the ArdA and Ocr proteins as functions 
of their intracellular concentrations (in RU) are shown in Fig. 6. While the Ocr protein 
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inhibited both activities of the EcoKI enzyme with similar efficiencies and acted already at 
extremely low concentrations in the cell, the antirestriction and antimodification activity 
curves substantially differed in the case of the ArdA protein. As estimations showed, the 
dissociation constant Kd(met) characteristic of ArdA_dependent inhibition of methylase 
activity of the EcoKI enzyme was tenfold higher than Kd(rest). 
The difference in inhibitory properties of the Ocr and ArdA proteins toward type I 
restriction–modification enzymes is probably determined by the difference in life cycle 
between phages and transmissible plasmids; i.e., a phage kills the cell, while a plasmid 
becomes part of cell genetic material. 
The ArdA proteins lose their capability of inhibiting modification activity of EcoKI_like 
proteins relatively easy. For instance, the ArdA antirestriction proteins encoded by the R16 
(incB) and R64 (incI1) transmissible plasmids inhibit restriction activity of the EcoKI enzyme, 
but do not affect its modification activity [25, 26]. Yet the proteins are highly homologous to 
the ColIb_P9 ArdA protein. In the 166 amino acid residues, differences are observed only in 
four positions with R64 ArdA and in nine positions with R16 ArdA. We have earlier found 
that certain single or double substitutions of hydrophobic amino acid resdues for negatively 
charged residues (D and E) in the region of the antirestriction motif abolish antimodification 
activity of ArdA encoded by the pKM101(incN) transmissible plasmid, while its its 
antirestriction activity is still preserved [17]. 
In this work, we used site_directed mutagenesis and constructed the ColIb_P9 ArdA mutant 
that contained three amino acid substitutions in the C_terminal domain; hydrophobic residues 
were replaced with a more hydrophobic one: F156I, F158I, and V163I.Activities of the mutant 
protein are characterized in Table 3. As is seen, the mutant protein inhibited antirestriction 
activity of the EcoKI enzyme, but lost the inhibitory effect on its modification activity. 
Likewise, certain amino acid substitutions transform the Ocr protein into an antirestriction 
protein that inhibits only antirestriction activity of the EcoKI enzyme. X_ray analysis of the Ocr 
protein in crystal demonstrates that a contact of the monomers in the (Ocr)2 homodimer is due 
to hydrophobic interactions between F53 and A57, which are in the hydrophobic fragment 
52_IFSVMAS_ in a short ǂ_helix [11]. We constructed an Ocr mutant with two substitutions, 
F53D and A57E, assuming that repulsion of negative charges (D…E) would lead to 
dissociation of the dimer. The 0.3(ocr) gene with a single or double mutation was cloned in the 
pUC18 vector. The Ocr F53D A 57E double mutant was tested for functional activity and 
proved to efficiently inhibit only EcoKI restriction activity without affecting methylase activity 
of the enzyme (Table 4, data on the antirestriction activity of the proteins are omitted). Note 
that the single amino acid substitutions of the interface region did not affect the 
antimodification activity of the Ocr protein (Table 4). Like the Ocr protein, the ArdA proteins 
are active in a homodimeric form. This is true for both the native ColIb_P9 ArdA protein and 
the R64 ArdA mutant, which is incapable of inhibiting methylase activity of the enzymes. 
Based on the data obtained for the Ocr and ArdA mutant proteins, we assume that the 
antirestriction proteins form complexes of two types with a type I restriction–modification 
type, which consists of five subunits (R2M2S) [27]. When an antirestriction protein interacts 
with the S subunit, which recognizes a specific site in DNA, the DNA strand is displaced, and 
both restriction and modification activities of the enzyme are inhibited. When an 
antirestriction protein interacts with the R subunit, which is responsible for ATP_dependent 
translocation and endonucleolytic cleavage of nonmethylated DNA, only restriction activity of 
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the enzyme is inhibited. To check this hypothesis, it was important to construct the Ocr 
mutants that were incapable of inhibiting methylase activity of the enzymes and preserved the 
effect on their restriction activity. Such properties were observed for the Ocr F53D A57E mutant, 
which was constructed in this work and had two substitutions of negatively charged amino 
acid residues for hydrophobic residues in the interface region of the (Ocr)2 homodimer. Thus, 
the model of type I restriction– modification enzymes with two different binding sites for 
antirestriction proteins is applicable not only to the ArdA proteins, whose genes are in 
transmissive plasmids, but also to the Ocr proteins, whose genes are in bacteriophage genomes. 
Anhydrotetracyclin, 
ng/ml 
Ocr 
concentration in 
the cell, RU 
EcoKI modification 
alleviation factor 
(R) for Ocr** 
EcoKI restriction 
alleviation factor 
(R) for Ocr 
0.0 (vector pZS33) 1 2000 2000 
0.0 (vector pZE21) 4 5000 5000 
0.2 6 5000 5000 
0.5 8 5000 5000 
1.0 12 5000 5000 
2.0 30 5000 5000 
5.0 150 5000 5000 
10.0 1000 5000 5000 
20.0 5000 5000 5000 
40.0 5000 5000 5000 
Notes: * The 0.3 (ocr) gene was cloned either in the pZE33 vector (row 1) or in the pZE21 vector (other 
rows) under the control of the P1tetO_1 promoter. 
** Here and in Table 3: Restriction or modification alleviation factor R = K+ / K–, where K– is the 
coefficient of restriction for MG1655Z1 cells without the plasmid containing the 0.3 (ocr) gene and K+ is 
the coefficient of restriction for MG1655Z1 cells carrying the plasmid. 
Table 1. Antimodification and antirestriction activities of the Ocr protein as dependent on its 
intracellular concentration* 
Anhydrotetracyclin, 
ng/ml 
Ard 
concentration in 
the cell, RU 
EcoKI modification 
alleviation factor 
(R) for ArdA 
EcoKI restriction 
alleviation factor 
(R) for ArdA** 
0.0 (vector pZS33) 1 Not determined Not determined 
0.0 (vector pZE21) 4 1 5 
0.2 6 1 6 
0.5 8 1 10 
1.0 12 1 20 
2.0 30 1 120 
5.0 150 4 400 
7.5 500 10 1000 
10.0 1000 100 2500 
15.0 4000 400 5000 
20.0 5000 1000 5000 
Table 2. Antimodification and antirestriction activities of the ColIb_P9 ArdA protein as 
dependent on its intracellular concentration* 
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We conclude that the dimeric form of an antirestriction protein is essential for inhibiting 
both activities of a type I restriction–modification system, while the monomeric form is 
sufficient for inhibition of its restriction activity. 
• The ardA gene was cloned in the pZE21 vector under the control of the P1 tetO_1 
promoter. 
 
Fig. 6. Antirestriction and antimodification activities of the ColIb_P9 ArdA and T7 Ocr 
proteins as functions of their intracellular concentrations. Curves: 1, antimodifi cation 
activity of Ocr; 2, antirestriction activity of Ocr;3, antimodification activity of ArdA; 4, 
antirestriction activity of ArdA. 
ArdA and Ocr differ considerably in their ability to inhibit the methylase (modification) 
activity of EcoKI-like enzymes. As a rule, if ardA and 0.3(ocr) genes are governed by a strong 
promoter, antirestriction and antimodification activities of ArdA and Ocr are established 
simultaneously ( Delver et al., 1991; Chilley & Wilkins, 1995;Atanasiu et al., 2002). Some data 
suggest, however, that the inhibition of endonuclease and methylase activities depends on 
different interactions of ArdA proteins with type I RM enzymes. For instance, some natural 
ArdA proteins inhibit only the endonuclease activity of EcoKI. The respective genes are 
located in transmissible plasmids R16 (incB) (Thomas et al., 2003) and R64 (incI1) (Zavilgelsky 
et al., 2004). Furthermore, in vitro quantification of the ArdA– EcoKI complex showed that 
ArdA interacts more efficiently with the complete enzyme R2M2S than with its methylase form 
M2S, which can only modify DNA (Nekrasov et al., 2007). In contrast to ArdA proteins, Ocr 
from phage T7 binds to the entire EcoKI enzyme and to its methylase form with nearly equal 
affinities (Atanasiu et al., 2002), and, therefore, even in very low concentrations it inhibits both 
the endonuclease and the methylase activities of the enzyme (Fig. 5). This property of Ocr is 
probably related to the difference between the life cycles of a phage and of a transmissible 
plasmid: a phage kills the host cell, whereas a plasmid becomes part of its genetic material. 
However, a double amino acid substitution in the 52IFSVMAS hydrophobic cluster of the Ocr 
interface (an Ocr homodimer is formed by a Van der Waals interaction between these clusters), 
that is, a substitution of acidic 53D and 57E for hydrophobic 53F and 57A (Fig. 6), causes the 
mutant protein Ocr F53D A57E to lose the antimethylation while retaining the antirestriction 
activity against EcoKI. In addition, the mutant protein Ocr F53D A57E has a Kd of 10 –7M, 
which is 1000 times higher than the Kd of the native Ocr form (Fig. 6) (Zavilgelsky et al., 2009). 
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Plasmid Protein 
Coefficient of 
restriction (K) of 
phage λ.0 on AB1157 
r+m+(**) 
Coefficient of 
restriction (K) of 
phage λjm109 on 
AB1157 r+m+ 
pUC18 Absent 2.0 x 10-4 1 
pVB2(pUC18) ArdA F1561 F1581 V1631 1 1 
pSR3(pUC18) ArdA native 1 2.0 x 10-4 
Notes: * Phage λ.0 was used to infect E. coli JM109 r–m+ cells. A phage lysate obtained after one 
reproduction cycle (λjm109) was titrated on strains TG_1 and AB1157. 
** The coefficient of restriction K (column 3), which was used to estimate the antirestriction activity of 
the ArdA proteins, was determined as the ratio of the titer of phage λ.0 on strain AB1157 to the titer of 
the same phage on strain TG_1 r–m–. 
Table 3. Effects of the ArdA (ColIb_P9) protein and its F156I F158I V163I mutant on EcoKI 
restriction and EcoKI modification in E. coli K_12 AB1157 r+ m+ and MJ109 r–m+* cells upon 
the cloning of the corresponding genes in the pUC18 vector 
Plasmid Protein 
Coefficient of 
restriction (K) of 
phage λjm109 
on TG1 r-m- 
Coefficient of 
restriction (K) of 
phage λjm109 on 
AB1157 r+m+ 
pUC18 Absent 1 1 
pSR8 Ocr native 1 2.0 x 10-4 
pSR9 Ocr F53D 1 2.0 x 10-4 
pSR10 Ocr A57E 1 2.0 x 10-4 
pSR11 Ocr F53D A57E 1 1 
* Phage λ.0 was used to infect E. coli JM109 r– m+ cells. A phage lysate obtained after one reproduction 
cycle (λjm109) was titrated on strains TG_1 and AB1157. The results were averaged over five replicate 
experiments. 
Table 4. Effects of the native and mutant T7 Ocr proteins on EcoKI_dependent modification 
in E. coli K_12 JM109 r– m+ cells* 
Kd is determined by intracellular protein concentration characterized with a 50% decrease in 
the inhibition of EcoKI endonuclease activity. For Ocr, this level was approximately 1700 
times lower than for ArdA. According to in vitro data, the Ocr–EcoKI complex formation 
had a Kd of 10 –10 M (Atanasiu et al., 2002). Therefore, the Kd for ArdA–EcoKI complex 
formation is 1.7×10–7M.  
The fact that endonuclease and methylase EcoKI activities are inhibited by ArdA or Ocr 
separately suggests that antirestriction proteins can bind type I enzymes in two ways: the 
complex formation of the first type inhibits both endonuclease and methylase activity of the 
enzyme, whereas in the complex of the second type, endonuclease activity is blocked while 
methylase activity is retained. As a working hypothesis, we propose the following model of 
interaction between antirestriction proteins (ArdA and Ocr) and type I RM enzymes (Fig. 7). 
ArdA and Ocr can form a complex both with the S-subunit that contacts with the sK site on 
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DNA, and with the R-subunit responsible for the translocation and cleavage of unmodified 
DNA. The binding of ArdA or Ocr to the S-subunit simultaneously inhibits both 
endonuclease and methylase activity by displacing DNA from its complex with the R2M2S 
enzyme (Fig. 7, 1). However, the binding can be easily disrupted if, as a result of amino acid 
substitutions, the protein is not in the dimeric form, or if the angle between the longitudinal 
axes of the monomers differs from the critical 34°. As a consequence, it becomes 
energetically unfavorable for a DNA-mimic protein to displace kinked DNA from its 
complex with the S-subunit. On the other hand, the interaction of ArdA or Ocr with the R-
subunit probably does not depend on the particular dimer structure, since the R-subunit is 
responsible for DNA strand translocation and the respective complex is not site-specific. 
Thus ArdA and Ocr inhibit only the endonuclease activity of the enzyme, while its 
methylase activity is preserved: DNA can still bind to the S-subunit, and the M-subunit 
specifically methylates adenyl residues at the sK site (Fig. 7, 2).  
 
Fig. 7. Putative scheme of ArdA or Ocr interaction with a type I RM enzyme (R2M2S). 1, An 
ArdA/Ocr complex with the S subunit: unmodified DNA is entirely displaced. Both 
endonuclease and methylase activities are inhibited (r– m– - phenotype). 2, An ArdA/Ocr 
complex with the R subunit: a DNA strand is displaced from the translocation center. Only 
endonuclease activity is inhibited (r– m+ phenotype). Endonuclease and methylase activities 
of a type I RM enzyme are designated as “r” and “m” respectively. 
In vitro experiments showed that the R2M2S form of EcoKI binds two (Ocr)2 dimers, while 
the methylase form M2 S binds only one (Atanasiu et al., 2002). This result fits well into the 
above model of inhibition by antirestriction proteins. As the ArdA binding constant is 
higher for M2S than for R2M2S, moderate levels of ArdA synthesized under natural 
conditions inhibit only the endonuclease activity of type I RM enzymes so as to protect the 
plasmid DNA in transmission, but do not affect the methylase activity which is crucial for 
maintaining the integrity of the plasmid and the host chromosome. The native Ocr form 
from phage T7 binds to RM enzymes, simultaneously inhibiting both the endonuclease and 
the methylase activity, and, therefore, interacts with the S-subunit. There is an obvious 
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reason for the Ocr activity being so high (Kd = 10–10 M): in the course of infection, the phage 
DNA is immediately attacked by cellular endonucleases. 
6. Pentapeptide repeat proteins (ppr proteins)  
6.1 Inhibitors of DNA gyrase 
Quinolones and also fluoroquinolones are synthetic derivatives of nalidixic acid; they 
belong to a group of antibiotics with wide spectrum of action and high activity and inhibit 
DNA gyrase. Quinolones bind to the gyrase–DNA complex. This results in stabilization of 
the covalent enzyme tyrosyl-DNA phosphate ester (a transient reaction intermediate) and 
causes death of bacteria. Quinolones have been successfully used for inactivation of 
Mycobacterium tuberculosis cells. During the first years of clinical use of quinolones, findings 
of M. tuberculosis strains resistant to quinolones were rather rare events. Studies of the 
nature of resistance to quinolones in the laboratory strains of M. tuberculosis and the related 
strain M. smegmotis have shown that this effect is determined by missense mutations (amino 
acid substitutions) in A-chain of DNA gyrase, or it represents the result of regulatory 
mutation potentiating expression of a protein pump responsible for the extracellular efflux 
of toxic compounds. However, the wide use of quinolones in medical practice resulted in 
the discovery of a new type of quinolone resistance. It was shown that the gene determining 
such type of resistance in M. smegmotis and M. tuberculosis encodes the MfpA protein, a 
specific inhibitor of DNA gyrase (Hegde et al., 2005; Montero et al., 2001). The MfpA 
proteins of M. tuberculosis and M. smegmotis consist of 183 and 192 residues correspondently; 
they share 67% identity. In 1998, the resistance to quinolones found in Klebsiella pneumoniae 
was shown to be encoded by the qnrA gene and transferred by the conjugated plasmid 
(Martinez-Martinez et al., 1998). Subsequent investigations have established that qnr genes 
have a worldwide distribution in a range of bacterial pathogens, mainly Gram-negative 
opportunist (particularly Enterobacteriaceae )(Robicsek et al., 2006). Sequence comparison of 
plasmids isolated from clinical Gram-negative strains differentiates five distinct qnr 
subfamilies qnrA, qnrB, qnrS (Jacoby et al., 2008), and most recently qnrC and qnrD (Wang et 
al., 2009; Cavaco et al., 2009). The proteins encoded by these genes exhibit the same function 
of DNA gyrase inhibition. 
MfpA and QnrABCDS proteins belong to the pentapeptide repeat protein (PRP) family. 
Amino acid sequences of these proteins contain a repeated pentapeptide with the consensus 
[S, T, A, V][D, N][L, F][S, T, R][G]. MfpA consists of 183 amino acid residues and in these 
pentapeptides each second amino acid is D or N and each third amino acid is L or F. Table1 
shows that MfpA protein consists of 30 pentapeptides, which determine characteristic 
features of its spatial structure. Figure 6a (taken from (Vetting et al., 2006) shows the spatial 
structure of the MfpA protein; it consists of a righ-handed ǃ-helix, which corresponds to B-
form DNA in size, shape, and electrostatics. In solutions, MfpA forms a dimer due to 
hydrophobic contact of several amino acids located at the C-end of an ǂ-helical site. The 
monomeric MfpA consists of eight coils, and four repeated pentapeptides form four sides of 
a quadrant (1-4) (Table 5). Such spatial structure was named RHQBH (right-handed 
quadrilateral beta-helix) or “Rfr” (Repeated five-residues). The dimer (MfpA)2 has a rod-like 
shape 100 angstrem in length and 27 angstrem in diameter. The total charge of the dimer is 
(–10), but the negative charges are distributed non-randomly. This results in (MfpA)2 dimer, 
which mimicks a 30 bp segment of B-form duplex DNA. Docking analysis revealed the 
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existence of tight contact between (MfpA)2 dimer and A2 dimer of the DNA gyrase A 
subunit (Fig. 8) due to electrostatic complementation between strongly cationic “seat” of the 
A2 dimer interface and a strongly anionic surface of the (MfpA)2 dimer.  
Structural analysis of the Aeromonas hydrophila, AhQnr protein is shown that it contain two 
prominent loops (1 and 2) that project from the PRP structure (Xiong et al., 2011). Deletion 
mutagenesis demonstrates that both contribute to the protection of Escherichia coli DNA 
gyrase from quinolones. A model for the Qnr:DNA gyrase interaction was suggested, where 
loop1 interacts with the gyrase A “tower” and loop2 with the gyrase B TOPRIM domains.   
Structural similarity between MfpA and Qnr proteins and DNA duplex of the gyrase 
substrate determines the effectiveness of competitive inhibition of the gyrase; this represents 
the molecular basis of bacterial resistance to quinolone antibiotics. It should be noted that in 
contrast to gyrase inhibition by quinolones, the inhibition of gyrase by MfpA and Qnr 
proteins is not accompanied by cell chromosome degradation. Consequently, the presence 
of the genes mfpA or qnr in the bacterial genome is very important because the “fee” for the 
rescue from the inactivating effect of antibiotics is delayed development of the cell. It is 
possible that the main function of DNA mimic inhibitors of gyrase consists in modulation of 
DNA supercoiling, which may potentiate supercoiling at the stage of DNA replication and 
decrease the rate of supercoiling when the level of chromosome compactness becomes 
optimal in a particular cell. 
6.2 Another PRP family proteins 
The first protein of the PRP family was originally found in Anabaena cyanobacteria (Black et 
al., 1995). The HglK protein (encoded by the hglK gene and consisting of 727 residues) 
contains a series of 36 tandem pentapeptides with the consensus sequence ADLSG. Using 
methods of bioinfor matics, a group of proteins belonging to PRP family has been identified 
in Synechocystis cyanobacteria; there are 15 proteins with series of tandem pentapeptide 
repeats varying from 13 to 44 (Bateman et al., 1998). By now the proteins of the PRP family 
have been found in almost all living organisms excluding yeasts. According to data analysis 
(Vetting et al., 2006), 525 proteins (484 prokaryotic and 41 eukaryotic) with the pentapep- 
tide motif have been identified. Sequencing of the genome of the cyanobacterium Cyanothece 
sp. PCC 51142 revealed 35 pentapeptide- containing proteins. It was determined (Buchko et 
al., 2006a) the spatial structure of the Rfr32 protein, which consists of 167 residues. The 
authors demonstrated that the 21 tandem pentapeptide repeats (with the consensus motif 
A(N/D)LXX) fold into a right-handed quadrilateral ǃ- helix, or Rfr-fold (as in the case of the 
MfpA protein); this structure imitates the rod-like structure of B-form DNA. The Rfr 
structure is also typical for another protein, Rfr23, encoded by a gene that has also been 
found in the genome of Cyanothece sp. PCC 51142 (Buchko et al., 2006b). The real functions of 
the pentapeptide-containing proteins found in cyanobacteria remain unknown. Some 
proteins determining immunity of bacteria to their own synthesized antibiotics also belong 
to the PRP family. These include the McbG protein (encoded by a mcbG gene located in the 
operon responsible for biosynthesis of microcin B17 (Pierrat & Maxwell, 2005) and the OxrA 
protein, which determines the resistance of Bacillus megatherium to oxetanocin A (Morita et 
al., 1999). In contrast to quinolones, microcin B17 interacts with B-subunit of DNA gyrase. A 
significant group of pentapeptide repeat family proteins has complex structure and contains  
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Fig. 8. Ribbon diagram of the Mycobacterium tuberculosis MfpA dimer. The four faced of the 
quadrilateral ǃ-helix are colored green (face 1), blue (face 2), yellow (face 3) and red (face 4). 
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several domains, including those with catalytic functions. However, the functional role of the 
pentapeptide repeats in this group remains unknown. But if the putative catalytic function of 
such protein consists of posttranslational modification of some DNA-binding protein (e.g. 
histone acetylation), one can suggest that binding of the target protein to the pentapeptide 
domain would significantly increase selectivity of such a modification reaction.  
Coil 
Quadrant sides Amino 
acid 
position in 
the protein 
chain 
1 2 3 4 
1 QQWVD CEFTG RDFRD EDLSR 21 
2 LHTER AMFSE CDFSG VNLAE 41 
3 SQHRG SAFRN CTFER TTLWH 61 
4 STFAQ CSMLG SVFVA CRLRP 81 
5 LTLDD VDFTL AVLGG NDLRG 101 
6 LNLTC CRLRE TSLVD TDLRK 121 
7 CVLRG ADLSG ARTTG ARLDD 141 
8 ADLRG ATVDP VLWRT ASLVG 161 
 ARVDV DQAVA FAAAH GLCLA 181 
Table 5. Position of pentapeptides along the axis of the MfpA protein molecule. 
7. Application of new DNA mimetics 
Since genes encoding DNA mimics (e.g. ardA and qnrABCDS) are located on transmission 
elements, transposons, and plasmids, this promotes their wide distribution among bacteria 
of various species and genera.  
Thus it is important to investigate in detail the structure of such proteins and the 
mechanisms of their action. The most illustrative example is the distribution of qnrABCDS 
genes responsible for the resistance to quinolone antibiotics among clinical bacterial strains. 
The search for and analysis of genes encoding DNA mimics and representing constituents of 
transmission elements are important tasks. Below we consider some putative variants of use 
of DNA-mimicking proteins. The DNA mimics may be successfully used for substitution of 
DNA during elucidation of spatial structure of the DNA-dependent enzymes by means of X-
ray analysis (Dryden, 2006). In some cases, it is difficult to obtain crystals of the complexes 
of the DNA dependent enzymes and DNA and it is possible that substitution of DNA by the 
DNA mimics may solve this problem. There are examples illustrating successful use of such 
substitutions: Ugi–UDG (Putnam &Tainer, 2005). It is suggested that substitution of DNA by 
the Ocr protein might be used for crystallization of Ocr in its complex with an S-subunit of 
EcoKI. Therefore, it should be noted that spatial structure of S-subunit of two type I 
restriction–modification enzymes has been determined (Kim et al., 2005; Calisto et al., 2005). 
The DNA mimics can be used in affinity chromatography. Affinity columns with a DNA 
mimics can be used with high effectiveness for detection and purification of various types of 
DNA-dependent enzymes. Use of radioactive or fluorescent labels will increase the 
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sensitivity of such method. The perspectives of in vitro construction of new types of DNA 
mimics (i.e. generation of proteins with different “design” and new functions) may be quite 
wide. These include potential tasks of constructing of DNA mimics, inhibiting or 
modulating activity of specific groups of DNA-dependent enzymes and tasks related to site 
directed changes in the structure of already known DNA mimics. Such works are rather 
successful. For example, using site-directed mutagenesis we have modified the structure of 
ArdA and Ocr; the modified proteins selectively inhibit the endonuclease (restriction) 
activity of type I restriction–modification enzymes without any influence on their methylase 
(modification) activity (Zavilgelsky et al., 2011). The use of such type of antirestriction 
proteins in gene engineering gives an opportunity to develop stable strains with hybrid 
plasmids because the process of specific modification of chromosome DNA remains 
unimpaired. The protein Ocr has already been used as an effective factor promoting 
significant increase of bacterial transformation by plasmids. Adding a small amount of the 
Ocr protein to solution with plasmid DNA causes significant (by several orders of 
magnitude) increase in effectiveness of cell transformation during electroporation. In this 
case unmethylated DNA and host bacteria with active type I restriction–modification system 
are used. The Ocr protein (as well as plasmid DNA) easily penetrates inside cells and 
immediately protects unmethylated DNA against degradation (EPICENTRE Forum 9, 8, 
htpp//www.epibio.com/forum.asp). 
The highly charged, very acidic proteins Ocr and ArdA may be used as a purification 
handle similar to other fusion tags. A monomeric mutant of the Ocr protein (13.8 kDa, very 
acidic, pI = 3.8) was used as a novel fusion tag whith displays solubilizing activity with a 
variety of different passenger proteins (DelProposto et al., 2009).  
In general, perspectives of the use of the DNA mimics might be related diagnostics and 
therapy of various diseases (e.g. for inhibition of specific enzymes and corresponding 
biochemical processes in cells).  
8. Conclusion 
Modern data on the mechanisms of the modulation of the DNA - binding enzymes by 
protein mimicry of DNA are reviewed. It has recently been demonstrated that DNA-binding 
enzymes can be controlled by the direct binding of a control protein to the DNA-binding site 
on the enzyme. The structures of these control proteins have been discovered to mimic the 
structure and electrostatics of DNA. Such DNA-mimics might be able to target bacterial 
restriction systems (Ocr, ArdA), drug resistance systems (MfpA, QnrABCS), as well as 
replication, recombination, and repair. It puts forward a range of potential uses of new DNA 
mimics in applied biotechnology.  
Figure 9 shows structures of Ocr and MfpA monomers and B-form DNA. Their comparison 
emphasizes the extraordinary capacities of living nature to develop unique forms crucial for 
adaptation. The most surprising thing is that nature has chosen different ways for design of 
proteins mimicking the DNA duplex. In one case (e.g. Ocr) these are tightly packed ǂ- 
helices, in the other it is a right-handed ǃ-helix (MfpA). Existence of significant negative 
charge (of the whole macromolecule or particular domain) required for similarity with the 
DNA polyanion is a common feature of DNA mimics. However, this is a necessary but not 
sufficient precondition. At the moment the only reliable method for detection of DNA 
mimics is X-ray analysis.  
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Fig. 9. The structures of Ocr(a) and MfpA(c) monomers and B-form of DNA(b) 
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